v3.25.1
Agreements and Transactions with VIE’s
3 Months Ended
Mar. 31, 2025
Agreements And Transactions With Vies  
Agreements and Transactions with VIE’s

Note 5 – Agreements and Transactions with VIE’s

 

The Company sells INVOcells to its consolidated and unconsolidated VIEs and anticipates continuing to do so in the ordinary course of business. All intercompany transactions with consolidated entities are eliminated in the Company’s consolidated financial statements. Pursuant to ASC 323-10-35-8, the Company eliminates any sales to an unconsolidated VIE for INVOcell inventory that the VIE still has remaining on the books at period end.

 

The following table summarizes the Company’s transactions with VIEs:

 

   2025   2024 
  

Three Months Ended

March 31,

 
   2025   2024 
Bloom INVO, LLC          
INVOcell revenue  $4,500   $10,500 
Unconsolidated VIEs          
INVOcell revenue  $2,970   $7,500)

 

The Company had balances with VIEs as follows:

 

  

March 31,

2025

  

December 31,

2024

 
Bloom INVO, LLC          
Accounts receivable  $42,000    37,500 
Notes payable   500,927    497,321 
Unconsolidated VIEs          
Accounts receivable  $25,500    22,500